- Home
- ARVN vs TBRG Comparison
ARVN vs TBRG Comparison
Compare ARVN & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- TBRG
- Stock Information
- Founded
- ARVN 2015
- TBRG 1979
- Country
- ARVN United States
- TBRG United States
- Employees
- ARVN N/A
- TBRG N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- TBRG
- Sector
- ARVN Health Care
- TBRG
- Exchange
- ARVN Nasdaq
- TBRG NYSE
- Market Cap
- ARVN 456.2M
- TBRG 393.0M
- IPO Year
- ARVN 2018
- TBRG N/A
- Fundamental
- Price
- ARVN $7.53
- TBRG $23.82
- Analyst Decision
- ARVN Buy
- TBRG Buy
- Analyst Count
- ARVN 21
- TBRG 3
- Target Price
- ARVN $20.53
- TBRG $23.67
- AVG Volume (30 Days)
- ARVN 2.2M
- TBRG 154.1K
- Earning Date
- ARVN 07-29-2025
- TBRG 05-07-2025
- Dividend Yield
- ARVN N/A
- TBRG N/A
- EPS Growth
- ARVN N/A
- TBRG N/A
- EPS
- ARVN N/A
- TBRG N/A
- Revenue
- ARVN $426,900,000.00
- TBRG $345,737,000.00
- Revenue This Year
- ARVN $2.83
- TBRG $5.15
- Revenue Next Year
- ARVN N/A
- TBRG $5.25
- P/E Ratio
- ARVN N/A
- TBRG N/A
- Revenue Growth
- ARVN 498.74
- TBRG 3.56
- 52 Week Low
- ARVN $5.90
- TBRG $9.33
- 52 Week High
- ARVN $34.11
- TBRG $32.00
- Technical
- Relative Strength Index (RSI)
- ARVN 54.38
- TBRG 42.03
- Support Level
- ARVN $6.70
- TBRG $23.38
- Resistance Level
- ARVN $7.60
- TBRG $24.90
- Average True Range (ATR)
- ARVN 0.45
- TBRG 0.79
- MACD
- ARVN 0.15
- TBRG -0.01
- Stochastic Oscillator
- ARVN 95.04
- TBRG 34.60
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are Revenue Cycle Management (RCM), (ii) Electronic Health Records (EHR), and (iii) Patient Engagement The company derives maximum revenue from the RCM segment.